COc1cc(OC)cc(-c2c(C#Cc3ccsc3)c3cc(-c4ccc(CN5CCOCC5)cc4)ccc3n2C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?